No black box warning on record for Adstiladrin

As of the latest FDA labeling reviewed, Adstiladrin (NADOFARAGENE FIRADENOVEC-VNCG) does not carry a black box warning. Standard warnings and precautions still apply — see the full Adstiladrin medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Delaying cystectomy could lead to the development of metastatic bladder cancer, which can be lethal. ( 5.1 ) Risk of disseminated adenovirus infection: Persons who are immunocompromised or immunodeficient may be at risk for disseminated infection from ADSTILADRIN due to low levels of replication-competent adenovirus. Avoid ADSTILADRIN exposure to immunocompromised or imm

No black box warning on record for Adstiladrin

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Delaying cystectomy could lead to the development of metastatic bladder cancer, which can be lethal. ( 5.1 ) Risk of disseminated adenovirus infection: Persons who are immunocompromised or immunodeficient may be at risk for disseminated infection from ADSTILADRIN due to low levels of replication-competent adenovirus. Avoid ADSTILADRIN exposure to immunocompromised or imm

Adstiladrin Black Box Warning

No black box warning on record for Adstiladrin

Other warnings & precautions

Adstiladrin Black Box Warning

No black box warning on record for Adstiladrin

Other warnings & precautions